Inhibition of microRNA-300 inhibits cell adhesion, migration, and invasion of prostate cancer cells by promoting the expression of DAB1

References

• Taylor BS, Schultz N, Hieronymus H, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18(1):11–22. .
   PubMed Web of Science ®Google Scholar
• Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63–89.
   PubMedGoogle Scholar
• Scher HI, Fizazi K, Saad F, et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med. 2012;367(13):1187–1197. .
   PubMed Web of Science ®Google Scholar
• Beltran H, Beer TM, Carducci MA, et al. New therapies for castration-resistant prostate cancer: efficacy and safety. Eur Urol. 2011;60(2):279–290. .
   PubMed Web of Science ®Google Scholar
• Huncharek M, Kupelnick B, Kupelnick B. Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. Am J Public Health. 2010;100(4):693–701.
   PubMed Web of Science ®Google Scholar
• Daniyal M, Siddiqui ZA, Akram M, et al. Epidemiology, etiology, diagnosis and treatment of prostate cancer. Asian Pac J Cancer Prev. 2014;15(22):9575–9578. .
   PubMedGoogle Scholar
• Ni J, Li Y, Li Y, et al. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway. Int J Biochem Cell Biol. 2013;45(12):2736–2748.
   PubMed Web of Science ®Google Scholar
• Wittmann D, Northouse L, Foley S, et al. The psychosocial aspects of sexual recovery after prostate cancer treatment. Int J Impot Res. 2009;21(2):99–106. .
   PubMed Web of Science ®Google Scholar
• Porkka KP, Pfeiffer MJ, Waltering KK, et al. MicroRNA expression profiling in prostate cancer. Cancer Res. 2007;67(13):6130–6135. .
   PubMed Web of Science ®Google Scholar
• Cruz FM, Tome M, Bernal JA, et al. miR-300 mediates Bmi1 function and regulates differentiation in primitive cardiac progenitors. Cell Death Dis. 2015;6(10):e1953. .
   PubMedGoogle Scholar
• Zhang Y, Guo Y, Yang C, et al. MicroRNA-300 targets hypoxia inducible factor-3 alpha to inhibit tumorigenesis of human non-small cell lung cancer. Neoplasma. 2017;64(4):554–562. .
   PubMed Web of Science ®Google Scholar
• Wang L, Yu P. miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53. Oncol Rep. 2016;36(6):3225–3232.
   PubMed Web of Science ®Google Scholar
• Zhang JQ, Chen S, Gu JN, et al. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/beta-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells. J Cell Biochem. 2018;119(1):1027–1040. .
   PubMed Web of Science ®Google Scholar
• McAvoy YZ S, Perez DS, James CD, et al. Disabled-1 is a large common fragile site gene, inactivated in multiple cancers. Genes Chromosomes Cancer. 2008;47:(2):165–174.
   PubMed Web of Science ®Google Scholar
• Huang Y, Magdaleno S, Hopkins R, et al. Tyrosine phosphorylated Disabled 1 recruits Crk family adapter proteins. Biochem Biophys Res Commun. 2004;318(1):204–212. .
   PubMed Web of Science ®Google Scholar
• Cao KL RJ, Xing WY, Du S, et al. Disabled-1 is down-regulated in clinical breast cancer and regulates cell apoptosis through NF-kappaB/Bcl-2/caspase-9. J Cell Mol Med. 2019;23:(2):1622–1627.
   PubMed Web of Science ®Google Scholar
• Fujikake K, Sawada M, Hikita T, et al. Detachment of chain-forming neuroblasts by Fyn-mediated control of cell–cell adhesion in the postnatal brain. J Neurosci. 2018;38(19):4598–4609. .
   PubMed Web of Science ®Google Scholar
• Albisinni S, Joniau S, Quackels T, et al. Current trends in patient enrollment for robotic-assisted laparoscopic prostatectomy in Belgium. Cancer. 2017;123(21):4139–4146. .
   PubMed Web of Science ®Google Scholar
• Brown RS, Wahl RL. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer. 1993;72:2979–2985.
   PubMed Web of Science ®Google Scholar
• Ning H, Albersen M, Lin G, et al. Effects of EdU labeling on mesenchymal stem cells. Cytotherapy. 2013;15(1):57–63. .
   PubMed Web of Science ®Google Scholar
• McDonald MV AC, Shen J, Sanda M, et al. Circulating microRNAs in plasma as potential biomarkers for the early detection of prostate cancer. Prostate. 2018;78(6):411–418.
   PubMed Web of Science ®Google Scholar
• Formosa A, Markert EK, Lena AM, et al. MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene. 2014;33(44):5173–5182. .
   PubMed Web of Science ®Google Scholar
• Jemal A, Xu J, Ward E. Cancer statistics. CA Cancer J Clin. 2010;60:277–300.
   PubMed Web of Science ®Google Scholar
• Bryant RJ, Pawlowski T, Catto JW, et al. Changes in circulating microRNA levels associated with prostate cancer. British Journal of Cancer. 2012;106(4):768–774..
   PubMed Web of Science ®Google Scholar
• Cao LIK R, Xing W, Wang Y, et al. Expression of Disabled-1 in human breast cancer cells and its role in cell cycle. J Jilin Univ. 2016;42:932–936.
   Google Scholar
• Schulze M, Violonchi C, Swoboda S, et al. RELN signaling modulates glioblastoma growth and substrate-dependent migration. Brain Pathol. 2018;28(5):695–709. .
   PubMed Web of Science ®Google Scholar
• Becker J, Frohlich J, Perske C, et al. Reelin signalling in neuroblastoma: migratory switch in metastatic stages. Int J Oncol. 2012;41(2):681–689. .
   PubMed Web of Science ®Google Scholar
• He FY, Liu HJ, Guo Q, et al. Reduced miR-300 expression predicts poor prognosis in patients with laryngeal squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 2017;21:760–764.
   PubMed Web of Science ®Google Scholar
• Engers R, Ziegler S, Mueller M, et al. Prognostic relevance of increased Rac GTPase expression in prostate carcinomas. Endocr Relat Cancer. 2007;14(2):245–256.
   PubMed Web of Science ®Google Scholar
• Zins K, Lucas T, Reichl P, et al. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice. PLoS One. 2013;8(9):e74924. .
   PubMed Web of Science ®Google Scholar
• Trudel YF D, Meyer F, Harel F, et al. Prostate cancer: MMP2, MMP9, MMP14, TIMP2 and disease-free survival. Cancer Res. 2004;64(7):1154. https://cancerres.aacrjournals.org/content/64/7_Supplement/264.1.short.
   Google Scholar
• Wegiel B, Bjartell A, Tuomela J, et al. Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis. J Natl Cancer Inst. 2008;100(14):1022–1036. .
   PubMedGoogle Scholar
• Fu CW M, Pestell RG, Pestell RG, et al. Minireview: cyclin D1: normal and abnormal functions. Endocrinology. 2004;145:(12):5439–5447.
   PubMed Web of Science ®Google Scholar
• Avci CB, Harman E, Dodurga Y, et al. Therapeutic potential of an anti-diabetic drug, metformin: alteration of miRNA expression in prostate cancer cells. Asian Pac J Cancer Prev. 2013;14(2):765–768.
   PubMedGoogle Scholar
• Schaefer A, Jung M, Kristiansen G, et al. MicroRNAs and cancer: current state and future perspectives in urologic oncology. Urol Oncol. 2010;28(1):4–13.
   PubMed Web of Science ®Google Scholar
• Sun L, Yao Y, Lu T, et al. DAB2IP downregulation enhances the proliferation and metastasis of human gastric cancer cells by derepressing the ERK1/2 pathway. Gastroenterol Res Pract. 2018;2018:2968252.
   PubMed Web of Science ®Google Scholar
• Qiao S, Homayouni R. Dab2IP regulates neuronal positioning, Rap1 activity and integrin signaling in the developing cortex. Dev Neurosci. 2015;37(2):131–141.
   PubMed Web of Science ®Google Scholar
• Zheng H, Gao L, Feng Y, et al. Down-regulation of Rap1GAP via promoter hypermethylation promotes melanoma cell proliferation, survival, and migration. Cancer Res. 2009;69(2):449–457.
   PubMed Web of Science ®Google Scholar
• Mathieu V, Pirker C, Schmidt WM, et al. Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation. Oncotarget. 2012;3(4):399–413.
   PubMedGoogle Scholar
• Shimizu Y, Hamazaki Y, Hattori M, et al. SPA-1 controls the invasion and metastasis of human prostate cancer. Cancer Sci. 2011;102(4):828–836.
   PubMed Web of Science ®Google Scholar
• Zhang YL, Wang RC, Cheng K, et al. Roles of Rap1 signaling in tumor cell migration and invasion. Cancer Biol Med. 2017;14(1):90–99.
   PubMed Web of Science ®Google Scholar